Critical reagents in flow cytometry, instrumentation and application in drug discovery development

Bioanalysis ◽  
2021 ◽  
Author(s):  
Vellalore N Kakkanaiah ◽  
Katie Matys ◽  
Patrick Bennett

Flow cytometer is a powerful cellular analysis tool consists of three main components; fluidics, optics and electronics. Flow cytometry methods have been used in all stages of drug development as like ligand binding assays (LBA). Both LBA and flow cytometry methods require specific interaction between the critical reagents and the analytes. Antibodies and their conjugates, viable dyes and permeabilizing buffer are the main critical reagents in flow cytometry methods. Similarly, antibodies, engineered proteins and their conjugates are the main critical reagents in LBA. The main difference between the two methods is the lack of true reference standards for flow cytometry cellular analysis.

Bioanalysis ◽  
2013 ◽  
Vol 5 (13) ◽  
pp. 1635-1648 ◽  
Author(s):  
Jin Wang ◽  
Vimal Patel ◽  
Daniel Burns ◽  
John Laycock ◽  
Kinnari Pandya ◽  
...  

2013 ◽  
pp. 647-657
Author(s):  
Jeffrey M. Sailstad ◽  
Ronald R. Bowsher ◽  
Omar F. Laterza ◽  
William Nowatzke

2001 ◽  
Vol 6 (2) ◽  
pp. 83-90 ◽  
Author(s):  
Bruce S. Edwards ◽  
Frederick W. Kuckuck ◽  
Erick R. Prossnitz ◽  
John T. Ransom ◽  
Larry A. Sklar

The flow cytometer is unique among biomedical analysis instruments because it makes simultaneous and multiple optical measurements on individual cells or particles at high rates. High throughput flow cytometry represents a potentially important multifactorial approach for screening large combinatorial libraries of compounds. Limiting this approach has been the availability of instrumentation and methods in flow cytometry for automated sample handling on the scale required for drug discovery applications. Here, we describe an automated system in which a novel patented fluidics-based pharmacology platform, the HTPS (High Throughput Pharmacological System), is coupled to a flow cytometer using a recently described plug flow-coupling valve technology. Individual samples are aspirated sequentially from microplate wells and delivered to a flow cytometer for rapid multiparametric analysis. For primary screening to detect and quantify cell fluorescence in endpoint assays, a high-speed no-wash protocol enabled processing of 9-10 cell samples/min from 96-well microplates. In an alternate primary screening format, soluble receptor ligands were sampled from microplate wells at rates of 3-4 samples/minute and successfully assessed for the ability to elicit intracellular calcium responses. Experiments with fluorescent beads validated the accurate automated production by the HTPS of exponential and linear gradients of soluble compounds. This feature enabled rapid (2- to 3-min) characterization of the intracellular calcium dose response of myeloid cells to formyl peptide as well as the quantitative relationship between formyl peptide receptor occupancy and cell response. HTPS flow cytometry thus represents a powerful high throughput multifactorial approach to increase the efficiency with which novel bioresponse-modifying drugs may be identified and characterized.


2015 ◽  
Vol 29 (9) ◽  
pp. 847-865 ◽  
Author(s):  
Hermann Wätzig ◽  
Imke Oltmann-Norden ◽  
Franziska Steinicke ◽  
Hassan A. Alhazmi ◽  
Markus Nachbar ◽  
...  

2015 ◽  
Vol 18 (1) ◽  
pp. 1-14 ◽  
Author(s):  
Darshana Jani ◽  
John Allinson ◽  
Flora Berisha ◽  
Kyra J. Cowan ◽  
Viswanath Devanarayan ◽  
...  

2009 ◽  
pp. 39-79 ◽  
Author(s):  
Masood N. Khan ◽  
Proveen D. Dass ◽  
John H. Leete ◽  
Richard F. Schuman ◽  
Michele Gunsior ◽  
...  

Bioanalysis ◽  
2021 ◽  
Author(s):  
Kevin Lang ◽  
Katie Matys ◽  
Patrick Bennett ◽  
Vellalore N Kakkanaiah

Multiparametric flow cytometry is a powerful cellular analysis tool used in various stages of drug development. In adoptive cell therapies, the flow cytometry methods are used for the evaluation of advanced cellular products during manufacturing and to monitor cellular kinetics after infusion. In this report, we discussed the bioanalytical method development challenges to monitor cellular kinetics in CAR-T cell therapies. These method development challenges include procuring positive control samples for the development of the method, flow cytometry panel design, LLOQ, prestain sample stability, staining reagents and data analysis.


Sign in / Sign up

Export Citation Format

Share Document